BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 15107975)

  • 1. [Tissue microarrays. High-throughput procedures to verify potential biomarkers].
    Kuefer R; Hofer MD; Gschwend JE; Rubin MA
    Urologe A; 2004 Jun; 43(6):659-67. PubMed ID: 15107975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue microarrays for miniaturized high-throughput molecular profiling of tumors.
    Simon R; Sauter G
    Exp Hematol; 2002 Dec; 30(12):1365-72. PubMed ID: 12482497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tissue microarray data exchange specification: implementation by the Cooperative Prostate Cancer Tissue Resource.
    Berman JJ; Datta M; Kajdacsy-Balla A; Melamed J; Orenstein J; Dobbin K; Patel A; Dhir R; Becich MJ
    BMC Bioinformatics; 2004 Feb; 5():19. PubMed ID: 15040818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protocols for Tissue Microarrays in Prostate Cancer Studies.
    Vlajnic T; Eppenberger-Castori S; Bubendorf L
    Methods Mol Biol; 2018; 1786():103-116. PubMed ID: 29786789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relational database structure to manage high-density tissue microarray data and images for pathology studies focusing on clinical outcome: the prostate specialized program of research excellence model.
    Manley S; Mucci NR; De Marzo AM; Rubin MA
    Am J Pathol; 2001 Sep; 159(3):837-43. PubMed ID: 11549576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies.
    Bubendorf L; Nocito A; Moch H; Sauter G
    J Pathol; 2001 Sep; 195(1):72-9. PubMed ID: 11568893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue microarrays (TMAs) for high-throughput molecular pathology research.
    Nocito A; Kononen J; Kallioniemi OP; Sauter G
    Int J Cancer; 2001 Oct; 94(1):1-5. PubMed ID: 11668471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of tissue microarrays in prostate cancer biomarker discovery.
    Datta MW; True LD; Nelson PS; Amin MB
    Adv Anat Pathol; 2007 Nov; 14(6):408-18. PubMed ID: 18049130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular high throughput research in prostate carcinoma].
    Schlomm T; Sültmann H; Poustka A; Sauter G; Hellwinkel OJ; Huland H
    Urologe A; 2007 Sep; 46(9):1097-100. PubMed ID: 17628772
    [No Abstract]   [Full Text] [Related]  

  • 10. Neuroendocrine expression in metastatic prostate cancer: evaluation of high throughput tissue microarrays to detect heterogeneous protein expression.
    Mucci NR; Akdas G; Manely S; Rubin MA
    Hum Pathol; 2000 Apr; 31(4):406-14. PubMed ID: 10821485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue microarrays.
    Henshall S
    J Mammary Gland Biol Neoplasia; 2003 Jul; 8(3):347-58. PubMed ID: 14973378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extent, impact, and mitigation of batch effects in tumor biomarker studies using tissue microarrays.
    Stopsack KH; Tyekucheva S; Wang M; Gerke TA; Vaselkiv JB; Penney KL; Kantoff PW; Finn SP; Fiorentino M; Loda M; Lotan TL; Parmigiani G; Mucci LA
    Elife; 2021 Dec; 10():. PubMed ID: 34939926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An improved method for constructing tissue microarrays from prostate needle biopsy specimens.
    McCarthy F; Fletcher A; Dennis N; Cummings C; O'Donnell H; Clark J; Flohr P; Vergis R; Jhavar S; Parker C; Cooper CS
    J Clin Pathol; 2009 Aug; 62(8):694-8. PubMed ID: 19638540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of constructing tissue microarrays from diagnostic prostate biopsies.
    Singh SS; Mehedint DC; Ford OH; Maygarden SJ; Ruiz B; Mohler JL
    Prostate; 2007 Jul; 67(10):1011-8. PubMed ID: 17476688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue microarrays in clinical urology--technical considerations.
    Kramer MW; Merseburger AS; Hennenlotter J; Kuczyk M
    Scand J Urol Nephrol; 2007; 41(6):478-84. PubMed ID: 17907050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence databases and microarrays as tools for identifying prostate cancer biomarkers.
    Grouse LH; Munson PJ; Nelson PS
    Urology; 2001 Apr; 57(4 Suppl 1):154-9. PubMed ID: 11295616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-density tissue microarrays from prostate needle biopsies.
    McCarthy F; Dennis N; Flohr P; Jhavar S; Parker C; Cooper CS
    J Clin Pathol; 2011 Jan; 64(1):88-90. PubMed ID: 21081515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue microarray (TMA) applications: implications for molecular medicine.
    Simon R; Sauter G
    Expert Rev Mol Med; 2003 Oct; 5(26):1-12. PubMed ID: 14987401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tissue microarray data exchange specification: a community-based, open source tool for sharing tissue microarray data.
    Berman JJ; Edgerton ME; Friedman BA
    BMC Med Inform Decis Mak; 2003 May; 3():5. PubMed ID: 12769826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From gene to clinic: TMA-based clinical validation of molecular markers in prostate cancer.
    Schlomm T; Chun FKh; Erbersdobler A
    Methods Mol Biol; 2010; 664():177-89. PubMed ID: 20690063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.